Pseudorotaxane nanofibers based on biomedical polymers, such as poly(ε-caprolactone) (PCL), and α-cyclodextrins (α-CD) open new horizons for a variety of biomedical applications.
No takes yet. Share an insight, caveat, or question.
Narayanan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: